PBI-Gordon issues Section 2(ee) recommendations for Kabuto Fungicide SC

By |  August 27, 2018 0 Comments
Kabuto-Fungicide-SC; Photo: PBI-Gordon Corp.

Photo: PBI-Gordon Corp.

PBI-Gordon Corp. issued Section 2(ee) recommendations for use of Kabuto Fungicide SC in select states for the treatment of spring dead spot (SDS) in warm-season turfgrass.

Labeled for use on golf courses, sports fields and residential and commercial turf, Kabuto is a proprietary formulation that inhibits all stages of development in the fungal life cycle of SDS. It can be applied up to eight times per year as part of a resistance management program.

“The Section 2(ee) recommendation highlights how Kabuto can be used to battle SDS, the most severe disease for warm-season turfgrasses, such as bermudagrass,” said Jim Goodrich, fungicide product manager for PBI-Gordon. “Extensive university and end-user testing has repeatedly shown that Kabuto outperforms competitive products in the effective treatment of SDS.”

This additional use recommendation is permitted under Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) in the following states but has not been submitted or approved by the EPA: Alabama, Arkansas, Arizona, California, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maryland, Missouri, Mississippi, North Carolina, New Mexico, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia.

The Section 2(ee) recommendations can be downloaded for various states, and for Texas. The applicator must have a copy of the recommendation present when treating for SDS.

According to PBI-Gordon Corp., other features of Kabuto include:

• A flowable (suspension concentrate) formulation;
• Highly effective at low- and high-use rates;
• No phytotoxicity concerns; and
• FRAC Group 7.

This article is tagged with and posted in Industry News

About the Author: Golfdom Staff

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc ac odio enim, nec placerat mi. Curabitur eget nisl quam. Vestibulum commodo, ligula sed accumsan hendrerit, augue quam interdum elit, id luctus augue sapien ac risus. In leo sapien, ullamcorper vitae adipiscing eu, mollis ac mauris. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc ac odio enim, nec placerat mi. Curabitur eget nisl quam. Vestibulum commodo, ligula sed accumsan hendrerit, augue quam interdum elit, id luctus augue sapien ac risus. Curabitur eget nisl quam. Vestibulum commodo, ligula sed accumsan hendrerit, augue quam interdum elit, id luctus augue sapien ac risus. In leo sapien, ullamcorper vitae adipiscing eu, mollis ac mauris.


Post a Comment